Oxidative stress may contribute to the pathogenesis of Parkinson's disease (PD). Paraoxonase 2 (PON2) is an ubiquitously expressed protein which displays antioxidant properties, though it does not have paraoxonase or arylesterase activity like other members of the PON gene family, such as PON1. Two coding region polymorphisms (Cys311Ser and Ala14Gly) of the PON2 gene were investigated by a newly developed method in a population-based case-control study of 179 PD patients and 293 controls. No statistically significant differences were found in the distribution of the wild type and mutant alleles between controls and PD. Similarly, no interactions between PON2 and two PON1 polymorphisms (192 and -108) were found. Polymorphisms of PON2 do not appear to be a risk factor for PD.

Paraoxonase 2 (PON2) polymorphisms and Parkinson's disease / Costa, Lucio Guido; S. N., Kelada; P., Costa Mallen; F. M., Farin; H. A., Viernes; T., Smith Weller; G. M., Franklin; W. T., Longstreth; P. D., Swanson; H., Checkoway; C. E., Furlong. - In: NEUROSCIENCE RESEARCH COMMUNICATIONS. - ISSN 0893-6609. - 34:(2004), pp. 130-135. [10.1002/nrc.20008]

Paraoxonase 2 (PON2) polymorphisms and Parkinson's disease

COSTA, Lucio Guido;
2004-01-01

Abstract

Oxidative stress may contribute to the pathogenesis of Parkinson's disease (PD). Paraoxonase 2 (PON2) is an ubiquitously expressed protein which displays antioxidant properties, though it does not have paraoxonase or arylesterase activity like other members of the PON gene family, such as PON1. Two coding region polymorphisms (Cys311Ser and Ala14Gly) of the PON2 gene were investigated by a newly developed method in a population-based case-control study of 179 PD patients and 293 controls. No statistically significant differences were found in the distribution of the wild type and mutant alleles between controls and PD. Similarly, no interactions between PON2 and two PON1 polymorphisms (192 and -108) were found. Polymorphisms of PON2 do not appear to be a risk factor for PD.
2004
Paraoxonase 2 (PON2) polymorphisms and Parkinson's disease / Costa, Lucio Guido; S. N., Kelada; P., Costa Mallen; F. M., Farin; H. A., Viernes; T., Smith Weller; G. M., Franklin; W. T., Longstreth; P. D., Swanson; H., Checkoway; C. E., Furlong. - In: NEUROSCIENCE RESEARCH COMMUNICATIONS. - ISSN 0893-6609. - 34:(2004), pp. 130-135. [10.1002/nrc.20008]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2326184
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact